arrow
S

Sarah E. Wilson

Public Health Ontario
H指数:30
被引数:3,695

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive Study

2021年至2022年加拿大儿童心肌炎和心包炎的主动监测:加拿大免疫监测计划ACTive研究

2025-05-130
OA
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection
HELIYON
IF3.6
2024-03-010
OAAI
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study

对世卫组织批准的新型冠状病毒肺炎疫苗的主动,以参与者为中心的预防接种后数字不良事件 (AEFI) 监测的范围审查: 加拿大预防接种研究网络研究

2024-02-191
OAAI
Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults

新型冠状病毒肺炎疫苗接种,先前的SARS-CoV-2感染或针对社区居住的成年人中与Omicron相关的严重结果的混合免疫所提供的保护

2023-11-246
OAAI
Pregnancy, fetal, and neonatal outcomes after a first booster dose of covid-19 vaccine during pregnancy in Ontario, Canada: population based, retrospective cohort study
2023-07-112
OAAI
Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy
2023-05-301
OAAI
?We need to protect each other?: COVID-19 vaccination intentions and concerns among Racialized minority and Indigenous Peoples in Canada

?我们需要互相保护?: 加拿大种族化少数民族和土著人民的新型冠状病毒肺炎疫苗接种意图和关切

2022-11-0120
OAAI
Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study

加拿大安大略省出现Omicron之前新型冠状病毒肺炎疫苗的有效性: 测试阴性设计研究

2022-09-079
OAAI